Status:
COMPLETED
Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?
Lead Sponsor:
University of Alberta
Conditions:
Warfarin
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Warfarin is a medication typically referred to as a blood thinner and is used to prevent the formation of blood clots, and hence prevent life-threatening events such as strokes and clots on the lungs ...
Eligibility Criteria
Inclusion
- current patient of the Anticoagulation Management Service
- anticipated need for long term anticoagulation
- have a regular primary care physician
Exclusion
- previous failure of warfarin therapy (a bleed or clot despite therapeutic anticoagulation
- have a planned procedure (surgery) mandating discontinuation of warfarin
- are taking warfarin for a mechanical valve indication
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00735189
Start Date
November 1 2007
End Date
April 1 2010
Last Update
June 24 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2C8